Daily News Podcast

Daily News Special: SABCS

Publish date: January 12, 2019

 

In this special edition of the MDedge Daily News, Nick Andrews and Terry Rudd report the latest news from the 2018 San Antonio Breast Cancer Symposium. Stories include: uUing low-dose tamoxifen, the latest findings from the KATHERINE trial, results of a meta-analysis of neoadjuvant chemotherapy, and capecitabine in early stage triple negative breast cancer.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

‘Strong evidence’ links obesity to cancers
MDedge Endocrinology
Focus on lifestyle to manage menopause symptoms after breast cancer
MDedge Endocrinology
Hyperlipidemia diagnosis protects against breast cancer
MDedge Endocrinology
Cancer patients with TKI-induced hypothyroidism had better survival rates
MDedge Endocrinology
E-health app helps weight loss, QOL for African American breast cancer survivors
MDedge Endocrinology
Newer hormonal contraception formulations linked to breast cancer risk*
MDedge Endocrinology
Think about breast cancer surveillance for transgender patients
MDedge Endocrinology
Hormone therapy raises diabetes risk in breast cancer survivors
MDedge Endocrinology
CTCs linked to late recurrence in HER2–, HR+ breast cancer
MDedge Endocrinology
Breast cancer risk in type 2 diabetes related to adiposity
MDedge Endocrinology